### Comment:
Nash is the disease Viking is focused on developing a drug for. Gilead has delayed results but I was pretty high on a company called GALT before. It's been awhile since I tracked it but it seems there hasnt been any advancements lately

### REPLY:
Viking is NAFLD, MDGL is NASH. 
  
 If you want the winner, its gonna be MDGL, but with that being said, it fell from its highs because I think a lot of people think the NASH market is overstated. I can see MDGL being taken out as a M&amp;A candidate before approval in 2021, but this may drop to the 50s if BeRnIe or WaRrEn gets the nomnom.

### END.